1 patient, T2 since mid-30s and now 59, had kidney transplant 2017 after end-stage diabetic nephropathy and fucked glucose control since 2019. The successful cells were endoderm stem cells from him cultivated by mice they injected with his PBMCs that they then made diabetic. So not from cadavers (except mouse cadaver i guess), which is the actual new part here. Intrahepatic implant, and cells from unrelated donor failed that were embedded at the same time. His personalised mouse-donor cells worked well enough to take him off insulin 3 months later.
It’s good news, but you’re entirely correct that the article missed the point entirely. Thanks for the crash course in islet cell therapy!
All the time. If it’s a company I dislike and I see them advertising on Google, I know I’m costing them money. Google uses an auction house system for ads, so common words can have a lot of competition. You could be making that company pay a dollar or more for that click, and at the same time contribute to a headache for their marketers who are keeping a close eye on their cost per click and customer acquisition costs.
Yeah, google wins in this scenario too, but there’s not much I can do about that.